RoseMarieDomingo-HorneMD

Neurology • Cambridge, MA

Neuromuscular Medicine

Medical Director, Global Medical Safety team at Biogen

Join to view full profile

Dr. Domingo-Horne is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Domingo-Horne's full profile

Already have an account?

Office
225 Binney St
Cambridge, MA 02142

Education & Training

Cleveland Clinic FoundationFellowship, Neuromuscular Medicine (Neurology), 2009 - 2010
Albany Medical CenterResidency, Neurology, 2006 - 2009
Albany Medical CenterInternship, Internal Medicine, 2005 - 2006
St. George's University School of MedicineClass of 2005

Certifications & Licensure

MA State Medical License 2013 - 2026
NY State Medical License 2010 - 2014
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Neuromuscular Medicine

Publications & Presentations

PubMed

Patient Preference for Subcutaneous Versus Intravenous Administration with Every-6-Week Natalizumab (Tysabri) Dosing: NOVA Phase IIIb Extension Study (Part 2).
Heinz Wiendl, John Foley, Gilles Defer, Lana Zhovtis Ryerson, Jeffrey A Cohen
Neurology and Therapy. 2024-10-01
The Reply.
Mohammad Kian Salajegheh, Rose M Domingo-Horne
The American Journal of Medicine. 2018-11-01
12 citations
An Approach to Myopathy for the Primary Care Clinician
Rose M. Domingo-Horne, Mohammad Salajegheh
The American Journal of Medicine. 2017-10-01

Journal Articles

Delayed radiation-induced lumbosacral radiculoplexus neuropathy – a diagnostic dilemma
Domingo-Horne RM, Neurol Disord Therap, 2007